Behind every scientific breakthrough is an environment that made it possible. But too often, infrastructure is treated as an afterthought – a cost to manage rather than a strategy to leverage.
X Axis, the quarterly newsletter by Rx Propellant, is designed to shift how life sciences infrastructure is understood and discussed.
In this April 2026 edition, we explore the evolving needs of science companies, from startup to scale-up and how infrastructure must adapt at every stage. We also examine why ESG is no longer just strategic, but fundamental to life sciences along with decoding the growing shift toward leasing in multi-tenanted R&D environments, a model quietly reshaping global biotech hubs.
Inside, you’ll also find a snapshot of Rx Propellant’s latest milestones, including new leadership appointment and a $100 million investment.
Download your copy today and start thinking about infrastructure the way the most forward-looking science companies already do.
